A Win For Wave Life Sciences Ltd.
Wed, Oct 16, 2024 at 07:48 PM
Wave Life Sciences Ltd. (WVE:NASDAQ) shot up at $14.9, representing a gain of 74.1%. On Wed, Oct 16, 2024, WVE:NASDAQ hit a New 2-Week High of $14.9. The stock got featured on our News Catalysts scanner on Wed, Oct 16, 2024 at 02:20 PM in the 'BIOTECH' category. From Wed, Oct 02, 2024, the stock recorded 40.00% Up Days and 63.64% Green Days
About Wave Life Sciences Ltd. (WVE:NASDAQ)
Wave Life Sciences Ltd is a preclinical therapeutics developer in Singapore. Its pipeline of drugs is intended to cure rare genetic disorders such as Huntington, duchenne muscular dystrophy (DMD) and inflammatory bowel disease.
Top 10 Gainers:
- Reneo Pharmaceuticals Inc. (RPHM:NASDAQ), 952.02%
- Santech Holdings Ltd ADS (STEC:NASDAQ), 646.89%
- 180 Life Sciences Corp. (ATNF:NASDAQ), 325.66%
- Versus Systems Inc. (VS:NASDAQ), 249.56%
- VS Media Holdings Limited (VSME:NASDAQ), 128.87%
- ProQR Therapeutics N.V. (PRQR:NASDAQ), 122.1%
- Korro Bio, Inc. (KRRO:NASDAQ), 93.66%
- Wave Life Sciences Ltd. (WVE:NASDAQ), 74.07%
- Biodexa Pharmaceuticals plc Sponsored ADR (New) 2023 (BDRX:NASDAQ), 73.55%
- Carmell Therapeutics Corporation Class A Common Stock (CTCX:NASDAQ), 67.63%